Terms: = Pancreatic cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
21 results:
1. u2af1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).
Nian Q; Li Y; Li J; Zhao L; Rodrigues Lima F; Zeng J; Liu R; Ye Z
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975232
[TBL] [Abstract] [Full Text] [Related]
2. Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of pancreatic Ductal Adenocarcinoma.
Kong Y; Luo Y; Zheng S; Yang J; Zhang D; Zhao Y; Zheng H; An M; Lin Y; Ai L; Diao X; Lin Q; Chen C; Chen R
Cancer Res; 2023 Sep; 83(18):3077-3094. PubMed ID: 37363990
[TBL] [Abstract] [Full Text] [Related]
3. CD44V3, an Alternatively Spliced Form of CD44, Promotes pancreatic cancer Progression.
Zhu H; Zhou W; Wan Y; Lu J; Ge K; Jia C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292918
[TBL] [Abstract] [Full Text] [Related]
4. The structure elucidation of novel arabinogalactan LRP1-S2 against pancreatic cancer cells growth in vitro and in vivo.
He F; Zhang S; Li Y; Chen X; Du Z; Shao C; Ding K
Carbohydr Polym; 2021 Sep; 267():118172. PubMed ID: 34119144
[TBL] [Abstract] [Full Text] [Related]
5. Considerations for feature selection using gene pairs and applications in large-scale dataset integration, novel oncogene discovery, and interpretable cancer screening.
Moody L; Chen H; Pan YX
BMC Med Genomics; 2020 Oct; 13(Suppl 10):148. PubMed ID: 33087122
[TBL] [Abstract] [Full Text] [Related]
6. The eighth version of American Joint Committee on cancer nodal classification for high grade pancreatic neuroendocrine tumor should be generalized for the whole population with this disease.
Li MX; Wang HY; Yuan CH; Ma CL; Jiang B; Li L; Zhang L; Zhao H; Cai JQ; Xiu DR
Medicine (Baltimore); 2020 Sep; 99(37):e22089. PubMed ID: 32925749
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
Kim SK; Takeda H; Takai A; Matsumoto T; Kakiuchi N; Yokoyama A; Yoshida K; Kaido T; Uemoto S; Minamiguchi S; Haga H; Shiraishi Y; Miyano S; Seno H; Ogawa S; Marusawa H
J Gastroenterol; 2019 Jul; 54(7):628-640. PubMed ID: 30756187
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).
Wildner D; Schellhaas B; Strack D; Goertz RS; Pfeifer L; Fiessler C; Neurath MF; Strobel D
Clin Hemorheol Microcirc; 2019; 71(1):39-51. PubMed ID: 29865043
[TBL] [Abstract] [Full Text] [Related]
9. Laparoscopic pancreaticoduodenectomy for tumors of the head of pancreas; 10 cases for a single center experience.
Caruso F; Alessandri G; Cesana G; Castello G; Uccelli M; Ciccarese F; Giorgi R; Villa R; Scotto B; Olmi S
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3745-3753. PubMed ID: 28975996
[TBL] [Abstract] [Full Text] [Related]
10. [A Study of Gemctabine plus Nab-Paclitaxel Therapy for Advanced Local Progressive pancreatic cancer].
Itoh Y; Saito H; Yamagishi S; Suematsu Y; Takahashi M; Nakayama M; Fukabori M; Morita A; Wakabayashi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1681-1683. PubMed ID: 28133097
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.
Trevisani F; Ghidini M; Larcher A; Lampis A; Lote H; Manunta P; Alibrandi MT; Zagato L; Citterio L; Dell'Antonio G; Carenzi C; Capasso G; Rugge M; Rigotti P; Bertini R; Cascione L; Briganti A; Salonia A; Benigni F; Braconi C; Fassan M; Hahne JC; Montorsi F; Valeri N
Br J Cancer; 2016 Nov; 115(11):1343-1350. PubMed ID: 27802451
[TBL] [Abstract] [Full Text] [Related]
12. Gastrointestinal tract tumors and cell lines possess differential splicing factor expression and tumor associated mRNA isoform formation profiles.
Jakubauskienė E; Peciuliene I; Vilys L; Mocevicius P; Vilkaitis G; Kanopka A
Cancer Biomark; 2015; 15(5):575-81. PubMed ID: 26406946
[TBL] [Abstract] [Full Text] [Related]
13. The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell Carcinoma.
Lee CC; Ho HC; Su YC; Lee MS; Hung SK; Chen YL
Medicine (Baltimore); 2015 Jul; 94(27):e1069. PubMed ID: 26166079
[TBL] [Abstract] [Full Text] [Related]
14. [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking].
Tian J; Zhu B; Tian Y; Zhong R; Miao X; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):710-3. PubMed ID: 25174478
[TBL] [Abstract] [Full Text] [Related]
15. Splicing factor mutations and cancer.
Yoshida K; Ogawa S
Wiley Interdiscip Rev RNA; 2014; 5(4):445-59. PubMed ID: 24523246
[TBL] [Abstract] [Full Text] [Related]
16. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
[TBL] [Abstract] [Full Text] [Related]
17. [Onconase: a ribonuclease with antitumor activity].
Zwolińska M; Smolewski P
Postepy Hig Med Dosw (Online); 2010 Feb; 64():58-66. PubMed ID: 20173221
[TBL] [Abstract] [Full Text] [Related]
18. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular u2af35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
Ding WQ; Kuntz SM; Miller LJ
Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
[TBL] [Abstract] [Full Text] [Related]
19. [Recent advances in tumor-seeking agents--radioimmunoimaging of cancers using monoclonal antibodies].
Hashimoto S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):866-72. PubMed ID: 2455482
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of CT scanning and radionuclide imaging in liver disease.
Friedman ML; Esposito FS
Crit Rev Diagn Imaging; 1980; 14(2):143-89. PubMed ID: 6258861
[TBL] [Abstract] [Full Text] [Related]
[Next]
